1 Day
Source:
الجمهوريّة
MPs address pharmaceutical price issues
A group of 17 deputies issued a statement expressing their concern over the review of prices for certain medications in Tunisia. They warn that such measures could negatively impact citizens who depend on regular, non-deferable treatments. The deputies believe that the medication problem is not limited to pricing alone but involves an entire system requiring serious reform, including governance, financing, relationships among stakeholders, the state of health institutions, and the role of social insurance funds. They also emphasize the need to develop a national pharmaceutical policy that ensures independence and health security. The deputies confirmed that the medication crisis results from longstanding accumulated issues and called for comprehensive reform to guarantee the availability of medicines and the sustainability of health institutions. They also urged the strengthening of the national pharmaceutical industry, greater transparency in setting drug prices, and protection for low-income groups, especially those with chronic illnesses. This statement comes after the Central Pharmacy issued a notice in July 2026 to update certain drug codes and increase prices for 12 medicines slightly, along with calls from the Pharmacy Owners Union for clear and transparent standards to ensure the continuous availability of medicines and compliance with citizens’ purchasing capacities.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)